These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37030500)

  • 1. Mismatch repair protein status of non-neoplastic uterine and intestinal mucosa in patients with Lynch syndrome and double somatic mismatch repair protein mutations.
    Freitag CE; Chen W; Pearlman R; Hampel H; Stanich PP; Cosgrove CM; Konnick EQ; Pritchard CC; Frankel WL
    Hum Pathol; 2023 Jul; 137():1-9. PubMed ID: 37030500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients.
    Hampel H; Pearlman R; de la Chapelle A; Pritchard CC; Zhao W; Jones D; Yilmaz A; Chen W; Frankel WL; Suarez AA; Cosgrove C; Backes F; Copeland L; Fowler J; O'Malley D; Salani R; McElroy JP; Stanich PP; Goodfellow P; Cohn DE
    Gynecol Oncol; 2021 Jan; 160(1):161-168. PubMed ID: 33393477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of DNA mismatch repair deficient crypts in random colonoscopic biopsies identifies Lynch syndrome patients.
    Brand RE; Dudley B; Karloski E; Das R; Fuhrer K; Pai RK; Pai RK
    Fam Cancer; 2020 Apr; 19(2):169-175. PubMed ID: 31997046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA mismatch repair-deficient non-neoplastic endometrial glands are common in Lynch syndrome patients and are present at a higher density than in the colon.
    Hegazy S; Brand RE; Dudley B; Karloski E; Bhargava R; Elishaev E; Pai RK
    Histopathology; 2021 Oct; 79(4):573-583. PubMed ID: 33847404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients.
    Wong S; Hui P; Buza N
    Mod Pathol; 2020 Jun; 33(6):1172-1181. PubMed ID: 31932681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation-specific Mismatch Repair-deficient Benign Endometrial Glands in Endometrial Biopsies and Curettings Are a Biomarker of Lynch Syndrome and Associate With Endometrial Carcinoma Development.
    Hegazy S; Brand RE; Dudley B; Karloski E; Lesnock JL; Elishaev E; Pai RK
    Am J Surg Pathol; 2023 Jul; 47(7):835-843. PubMed ID: 37226842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histology of colorectal adenocarcinoma with double somatic mismatch-repair mutations is indistinguishable from those caused by Lynch syndrome.
    Hemminger JA; Pearlman R; Haraldsdottir S; Knight D; Jonasson JG; Pritchard CC; Hampel H; Frankel WL
    Hum Pathol; 2018 Aug; 78():125-130. PubMed ID: 29723603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome.
    Walker R; Mahmood K; Joo JE; Clendenning M; Georgeson P; Como J; Joseland S; Preston SG; Antill Y; Austin R; Boussioutas A; Bowman M; Burke J; Campbell A; Daneshvar S; Edwards E; Gleeson M; Goodwin A; Harris MT; Henderson A; Higgins M; Hopper JL; Hutchinson RA; Ip E; Isbister J; Kasem K; Marfan H; Milnes D; Ng A; Nichols C; O'Connell S; Pachter N; Pope BJ; Poplawski N; Ragunathan A; Smyth C; Spigelman A; Storey K; Susman R; Taylor JA; Warwick L; Wilding M; Williams R; Win AK; Walsh MD; Macrae FA; Jenkins MA; Rosty C; Winship IM; Buchanan DD;
    J Transl Med; 2023 Apr; 21(1):282. PubMed ID: 37101184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for evaluating breast cancers of Lynch syndrome patients for mismatch repair gene expression.
    Sorscher S
    Breast Cancer Res Treat; 2019 Nov; 178(2):469-471. PubMed ID: 31392519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mismatch repair deficient-crypts in non-neoplastic colonic mucosa in Lynch syndrome: insights from an illustrative case.
    Shia J; Stadler ZK; Weiser MR; Vakiani E; Mendelsohn R; Markowitz AJ; Shike M; Boland CR; Klimstra DS
    Fam Cancer; 2015 Mar; 14(1):61-8. PubMed ID: 25173403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA mismatch repair protein deficient non-neoplastic colonic crypts: a novel indicator of Lynch syndrome.
    Pai RK; Dudley B; Karloski E; Brand RE; O'Callaghan N; Rosty C; Buchanan DD; Jenkins MA; Thibodeau SN; French AJ; Lindor NM; Pai RK
    Mod Pathol; 2018 Oct; 31(10):1608-1618. PubMed ID: 29884888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome.
    Pearlman R; Haraldsdottir S; de la Chapelle A; Jonasson JG; Liyanarachchi S; Frankel WL; Rafnar T; Stefansson K; Pritchard CC; Hampel H
    J Med Genet; 2019 Jul; 56(7):462-470. PubMed ID: 30877237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome.
    Ito T; Yamaguchi T; Kumamoto K; Suzuki O; Chika N; Kawakami S; Nagai T; Igawa T; Fujiyoshi K; Akagi Y; Arai T; Akagi K; Eguchi H; Okazaki Y; Ishida H
    Int J Clin Oncol; 2024 Jul; 29(7):953-963. PubMed ID: 38615286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.
    Mills AM; Liou S; Ford JM; Berek JS; Pai RK; Longacre TA
    Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly Sensitive Microsatellite Instability and Immunohistochemistry Assessment in Endometrial Aspirates as a Tool for Cancer Risk Individualization in Lynch Syndrome.
    Canet-Hermida J; Marín F; Dorca E; Dueñas N; Costas L; Salinas M; Velasco À; Peremiquel-Trillas P; Paytubi S; Ponce J; Fernández S; Martínez JM; Cárdenas L; Taltavull A; Alemany L; Meléndez C; Oliveras G; Vidal A; Capellá G; López-Bonet E; Brunet J; Matias-Guiu X; Pineda M
    Mod Pathol; 2023 Jul; 36(7):100158. PubMed ID: 36918055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch repair-deficient crypt foci in Lynch syndrome--molecular alterations and association with clinical parameters.
    Staffa L; Echterdiek F; Nelius N; Benner A; Werft W; Lahrmann B; Grabe N; Schneider M; Tariverdian M; von Knebel Doeberitz M; Bläker H; Kloor M
    PLoS One; 2015; 10(3):e0121980. PubMed ID: 25816162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Mismatch Repair Gene Variant Classification: Evaluating the Utility of Somatic Mutations and Mismatch Repair Deficient Colonic Crypts and Endometrial Glands.
    Walker R; Mahmood K; Como J; Clendenning M; Joo JE; Georgeson P; Joseland S; Preston SG; Pope BJ; Chan JM; Austin R; Bojadzieva J; Campbell A; Edwards E; Gleeson M; Goodwin A; Harris MT; Ip E; Kirk J; Mansour J; Mar Fan H; Nichols C; Pachter N; Ragunathan A; Spigelman A; Susman R; Christie M; Jenkins MA; Pai RK; Rosty C; Macrae FA; Winship IM; Buchanan DD;
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 Expression in Mismatch Repair-deficient Endometrial Carcinomas, Including Lynch Syndrome-associated and MLH1 Promoter Hypermethylated Tumors.
    Sloan EA; Ring KL; Willis BC; Modesitt SC; Mills AM
    Am J Surg Pathol; 2017 Mar; 41(3):326-333. PubMed ID: 27984238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.